Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

Go back to Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
(NASDAQ: MRKR) Delayed: 1.02 -0.05 (4.67%)
Previous Close $1.07    52 Week High $ 
Open $1.07    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.02    EPS $ 
Volume 35,966